Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
TDH Holdings, Inc. Reports Full Year 2023 Audited Financial ResultsPR Newswire
FCPT Announces Acquisition of a Patient First Urgent Care Property for $6.6 MillionBusiness Wire
Southern California NIRI Chapters and Nasdaq Host the 2nd Annual NIRI SoCal ConferenceBusiness Wire
NEXE Innovations Announces Quarterly Q3 2024 Financial Results for the Three-Month Period Ended February 29, 2024Canada Newswire
NEXE Innovations Announces Quarterly Q3 2024 Financial Results for the Three-Month Period Ended February 29, 2024PR Newswire
QYOU Media Reports FY 2023 ResultsPR Newswire
QYOU Media Reports FY 2023 ResultsCanada Newswire
CANASIA ANNOUNCES DECEMBER 31, 2023 CONTINGENT BITUMEN RESOURCES FOR SAWN LAKE, ALBERTA SAGD PROJECT OF ANDORA ENERGY CORPORATION AND SELECTION OF ANDORA ENERGY CORPORATION AS SUCCESSFUL BIDDER TO ACQUIRE ADDITIONAL SAWN LAKE ASSETS FROM RECEIVERSHIPCanada Newswire
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)PR Newswire
ECONOMIC INVESTMENT TRUST LIMITED ANNOUNCES DIVIDENDCanada Newswire
X Financial Files Annual Report on Form 20-F for Fiscal Year 2023PR Newswire
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)PR Newswire
FIRSTFUND REPORTS 2023 FOURTH QUARTER RESULTSCanada Newswire
ECONOMIC INVESTMENT TRUST LIMITED ANNOUNCES OUTCOME OF DIRECTOR ELECTIONSCanada Newswire
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)PR Newswire
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)PR Newswire
Pond Technologies Holdings Inc. Announces Filing of 2023 Audited Financial Statements and MD&ACanada Newswire
Canadian Utilities to Share Strategic Update at Annual General Meeting on May 8, 2024Canada Newswire
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerBusiness Wire
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerBusiness Wire
RNS announcements are delayed by up to an hour.
...